Guangdong Association Of Clinical Trials
Clinical trials sponsored by Guangdong Association Of Clinical Trials, explained in plain language.
-
New drug IBI351 shows promise for tough lung cancer in Real-World review
Disease control Not yet recruitingThis study reviews medical records of 600 Chinese patients with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. All patients received the drug IBI351 between August 2024 and August 2025. Researchers will measure how many patients' tumors s…
Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for lung cancer patients whose immunotherapy stopped working
Disease control Not yet recruitingThis study tests a combination of two drugs, chidamide and ivonescimab, in 32 adults with advanced non-small cell lung cancer that has stopped responding to immunotherapy and has high levels of a protein called YAP. The goal is to see if the combo can shrink tumors or delay cance…
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
New Four-Drug attack on Tough-to-Treat lung cancer
Disease control Not yet recruitingThis study is testing a combination of four drugs (QL1706, chemotherapy, and bevacizumab) for people with advanced non-squamous lung cancer. It is for patients whose cancer has a specific genetic change and has stopped responding to prior targeted therapy. The main goal is to see…
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Apr 21, 2026 12:44 UTC